![]() |
市場調査レポート
商品コード
1738743
脳波測定装置の世界市場規模:製品別、用途別、エンドユーザー別、地域範囲別および予測Global Electroencephalography Devices Market Size By Product, By Application, By End-User, By Geographic Scope And Forecast |
||||||
|
脳波測定装置の世界市場規模:製品別、用途別、エンドユーザー別、地域範囲別および予測 |
出版日: 2025年05月05日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
|
脳波検査装置の市場規模は、2024年に20億4,000万米ドルと評価され、2026~2032年にかけてCAGR 8.70%で成長し、2032年には37億4,000万米ドルに達すると予測されています。
脳波測定(EEG)装置は、脳内の自発的な電気活動のエレクトログラムを記録する技術です。
脳波測定装置は、非侵襲的な方法で脳の電気活動をモニターする電子装置です。この技術は、患者の頭部に固定された小さな金属ディスク(電極)を用いて、脳の電気インパルスを検出します。電気インパルスは非常に弱いため、電圧を上げるための増幅器が必要となります。
EEG装置の結果は、睡眠障害のモニタリング、麻酔薬の適切な投与量の決定、てんかん、パーキンソン病、アルツハイマー病などさまざまな神経疾患の診断に用いられます。EEG装置は、病院、診断ラボ、神経科などで一般的に使用されています。
より優れた脳モニタリング装置を製造するためのメーカーによる研究開発努力の高まりも、脳波システム市場の成長を促す顕著な要因です。企業は、先進的技術に対する需要の高まりに対応するため、既存の商品を改良し、新しい商品を生み出すための研究開発に費やしています。
世界の脳波装置市場を形成している主要な市場力学は以下の通りです。
主要市場促進要因
神経疾患の有病率の増加:てんかん、アルツハイマー病、パーキンソン病、脳卒中などの神経疾患の世界の発生率が上昇するにつれて、診断、モニタリング、治療のためのEEG装置に対する需要も増加します。
遠隔医療と遠隔患者モニタリングの増加:遠隔医療と遠隔患者モニタリングのオプションは、特にCOVID-19の流行を考慮して、ますます人気が高まっています。遠隔モニタリング機能を備えたEEG装置は、ヘルスケア担当者が患者の脳活動を遠隔で検査・モニタリングすることを可能にし、より迅速な介入を可能にし、対面診察の必要性を減少させています。
ブレインコンピュータインターフェース(BCI)技術の応用拡大:BCI技術は、脳波を介してコンピュータや他の装置と接続することを可能にします。EEG装置はBCIシステムの重要なコンポーネントであり、リハビリテーション、コミュニケーション、エンターテイメントにおける斬新な応用を可能にします。
ヘルスケア支出の増加:ヘルスケア支出が世界的に増加するにつれて、病院やクリニックはEEGガジェットなどの最新診断装置に投資する資源をより多く持つようになります。
主要課題
装置のコスト:EEG装置は高価であるため、医療施設や個人によっては手が届かないこともあります。品質を維持しながらEEG装置のコストを削減することは重大な課題です。
電極配置と信号品質:正確な脳波測定には適切な電極配置が必要です。不適切な配置は信号の質を低下させ、予測不可能な結果をもたらす可能性があります。使いやすい電極挿入技術の開発と一定の信号品質の維持は、現在進行中の問題です。
ノイズと干渉:EEG信号は、モーションアーチファクトや電磁干渉を含むさまざまな発生源からのノイズや干渉の影響を受ける可能性があります。ノイズと干渉を最小化してクリーンなEEG測定値を生成することは、装置設計者にとって大きな問題です。
産業の競合と革新:EEG装置産業は競争が激しく、多くの企業が新技術の革新と導入にしのぎを削っています。競合他社に先んじ、変化する顧客の要望を満たすために常に発明し続けることは、このビジネスに携わるメーカーにとって難しいことです。
主要動向
ワイヤレスとウェアラブルデバイスへのシフト:従来型EEGシステムは、膨大な数の電極と接続のために不便でした。市場はワイヤレスとウェアラブルEEG装置へとシフトしており、これらの装置は患者により良い快適性と機動性を記載しています。これらの装置は、睡眠モニタリングや外来脳波モニタリングなどの用途に特に有用です。
AI統合への注力:AIは脳波分析においてますます重要性を増しています。AIアルゴリズムは、脳波データの分析を自動化し、精度と効率を高め、解釈時間を最小限に抑えるのに役立ちます。これは早期診断や治療計画に役立ちます。
低価格脳波装置の開発:EEG装置は従来高価であったため、地域によってはその利用が制限されていました。低価格のEEG装置が利用可能になることで、この技術はより幅広いヘルスケア提供者や患者にとってより身近なものとなります。
拡張現実(AR)と仮想現実(VR)との統合:EEG装置をARやVR技術と組み合わせることへの関心が高まっています。これはニューロフィードバック療法、認知トレーニング、リハビリテーションに応用できます。
Electroencephalography Devices Market size was valued at USD 2.04 Billion in 2024 and is projected to reach USD 3.74 Billion by 2032, growing at a CAGR of 8.70% from 2026 to 2032.
Electroencephalography (EEG) is a technique for recording an electrogram of spontaneous electrical activity in the brain.
An electroencephalograph is an electronic device that uses a non-invasive way to monitor the electrical activity of the brain. The technology detects electrical brain impulses using small metal discs (electrodes) fixed to the patient's head. Because the electrical impulses are so weak, an amplifier is required to increase the voltage.
The results of EEG equipment are used to monitor sleep disorders, determine the appropriate dosage of anesthetic and diagnose a variety of neurological illnesses such as epilepsy, Parkinson's disease, and Alzheimer's. EEG equipment is commonly used in hospitals, diagnostic labs, and neurology departments, among other settings.
Rising R&D efforts by manufacturers to produce better brain monitoring devices are another prominent factor driving the growth of the electroencephalography systems market. Companies are spending in R&D to improve existing goods and create new ones to meet the growing demand for advanced technologies.
The key market dynamics that are shaping the global electroencephalography devices market include:
Key Market Drivers:
Growing Prevalence of Neurological Illnesses: As the global incidence of neurological illnesses such as epilepsy, Alzheimer's disease, Parkinson's disease, and stroke rises, so does the demand for EEG devices for diagnosis, monitoring, and treatment.
Rise in Telemedicine and Remote Patient Monitoring: Telemedicine and remote patient monitoring options are becoming increasingly popular, particularly in light of the COVID-19 epidemic. EEG equipment with remote monitoring capabilities enables healthcare personnel to remotely examine and monitor patients' brain activity, allowing for more rapid interventions and decreasing the need for in-person consultations.
Expanding Applications for Brain-Computer Interface (BCI) Technology: BCI technology enables people to connect with computers or other devices via their brainwaves. EEG devices serve as a key component of BCI systems, enabling novel applications in rehabilitation, communication, and entertainment.
Increasing Healthcare Expenditure: As healthcare expenditure grows globally, hospitals and clinics have greater resources to invest in modern diagnostic equipment such as EEG gadgets.
Key Challenges:
Cost of Devices: EEG equipment can be expensive, making them affordable for some healthcare facilities or individuals. Reducing the cost of EEG devices while maintaining quality is a serious challenge.
Electrode Placement and Signal Quality: Accurate EEG readings require proper electrode placement. Incorrect placement can result in poor signal quality and unpredictable results. Developing user-friendly electrode insertion techniques and maintaining constant signal quality are ongoing problems.
Noise and Interference: EEG signals can be affected by noise and interference from a variety of sources, including motion artifacts and electromagnetic interference. Minimizing noise and interference to generate clean EEG readings is a major problem for equipment designers.
Industry Competition and Innovation: The EEG device industry is highly competitive, with many businesses competing to innovate and introduce new technology. Staying ahead of competitors and always inventing to fulfill changing customer wants is difficult for manufacturers in this business.
Key Trends:
Shift to Wireless and Wearable Devices: Traditional EEG systems are inconvenient due to the huge number of electrodes and connections. The market is shifting towards wireless and wearable EEG equipment, which provide patients with better comfort and mobility. These devices are especially useful for applications such as sleep monitoring and ambulatory EEG monitoring.
Focus on AI Integration: AI is becoming increasingly significant in EEG analysis. AI algorithms can help automate the analysis of EEG data increasing accuracy, efficiency, and minimizing interpretation time. This is useful for early diagnosis and therapy planning.
Development of Low-Cost EEG Devices: EEG devices have traditionally been expensive, limiting their availability in some areas. The availability of low-cost EEG equipment makes this technology more accessible to a wider variety of healthcare providers and patients.
Integration with Augmented Reality (AR) and Virtual Reality (VR): There is rising interest in combining EEG devices with AR and VR technology. This could be applied to neurofeedback therapy, cognitive training, and rehabilitation.
Here is a more detailed regional analysis of the global electroencephalography devices market:
North America:
In 2022, North America emerged as the market leader for electroencephalogram (EEG) devices, with a market share of roughly 39%. Europe and Asia Pacific are the second and third dominating regions, respectively. Several significant aspects contribute to the region's leadership. To begin, the prevalence of numerous sleep and neurological problems has increased significantly across North America. This rising incidence, combined with increased access to insurance coverage, has played a crucial role in the region's EEG device uptake.
Furthermore, North America has a well-developed healthcare system, which makes it ideal for the broad use of EEG equipment. The presence of strong distribution and sales networks created by prominent vendors contributes to market expansion in the region.
Besides, advantageous payment policies in the United States have accelerated the use of EEG equipment to diagnose neurological illnesses. These policies have encouraged healthcare practitioners to include EEG technology into their diagnostic regimens, resulting in increased market growth.
Being a part of esteemed government agencies such as the National Institute of Neurological Disorders and Stroke (NINDS) has had a significant impact on the EEG device market environment in North America. These factors collectively highlight the region's importance as a primary driver of growth and innovation in the EEG devices market.
Europe:
Europe is expected to increase consistently over the projection period, thanks to its well-established healthcare system. With a strong infrastructure in place, the region creates an ideal setting for the adoption and use of EEG devices. Furthermore, the presence of non-profit organizations, such as the European Multiple Sclerosis Platform (EMSP), is projected to accelerate market growth.
The establishment of organizations such as EMSP demonstrates Europe's dedication to treating neurological illnesses. According to EMSP, around 9 million people in Europe suffer from neurodegenerative disorders. By campaigning for research programs and fostering data collecting, EMSP helps to advance knowledge and understanding of illnesses like multiple sclerosis across Europe and beyond.
Europe's consistent growth trajectory in the EEG device market is supported by a well-established healthcare system and collaborative efforts by organizations such as EMSP to tackle neurological illnesses. By fostering research, data gathering, and awareness activities, these organizations help to expand the market and enhance EEG technology in the region.
Asia Pacific:
During the forecast period of 2022 to 2029, Asia-Pacific (APAC) is expected to enjoy significant growth in the EEG devices market, driven mostly by the region's growing geriatric population. As APAC nations' demographics transition, with an increasing proportion of elderly citizens, demand for healthcare services, especially neurological diagnostics, is likely to rise.
The rapidly growing senior population in Asia-Pacific represents a huge market opportunity for EEG device manufacturers and healthcare providers. As age-related neurological illnesses become more common, there is an increasing demand for improved diagnostic tools like EEG equipment to help in the early diagnosis, monitoring, and management of these conditions.
Overall, the expected expansion of the EEG devices market in Asia-Pacific during the forecast period is driven by demographic factors such as an aging population and the resulting increase in demand for neurological diagnostic solutions. This provides great potential for market participants to increase their presence in the region and fulfill the changing healthcare needs of APAC countries.
The Global Electroencephalography Devices Market is segmented on the basis of Product, Application, End User, And Geography.
Based on the Product type, the market is segmented into Portable EEG Devices, Standalone EEG Devices and Wireless EEG Devices. Standalone EEG devices now dominate the Electroencephalography market, with hospitals and clinics preferring them because to the considerable functionality required in clinical and research environments.
Based on the Application, the market is segmented into Disease Diagnosis, Sleep Monitoring, Anesthesia Monitoring, Brain-Computer Interfaces (BCIs) and Research. The most common application is currently disease diagnosis and it is projected to dominate the market. This is because EEG is used to diagnose a variety of neurological illnesses, including epilepsy, Alzheimer's, and Parkinson's disease. Hospitals and clinics rely heavily on EEG for these applications due to its accuracy.
Based on End-User, the market is fragmented into Hospitals, Neurology Clinics, Ambulatory, Surgical Centers, Diagnostic Centers, Academic and Research Institutions and Homecare. In the EEG devices market, while hospitals currently dominate due to their extensive needs for diagnosis, treatment, and research, the fastest-growing segment is expected to be home care.
The "Global Electroencephalography Device Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Jordan NeuroScience Inc., Cadwell Industries Inc., Compumedics Limited, NeuroWave Systems, Inc., Natus Medical Incorporated, NIHON KOHDEN CORPORATION, NeuroSky, Bio-Signal Group Corp., Elekta AB, Lifelines Neuro, Neurosoft S.A., EMS Handels Gesellschaft mbH, BrainScope Company, Inc., Advanced Brain Monitoring, Inc., EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, Electrical Geodesics, Inc., Masimo, ELMIKO MEDICAL sp. Z oo, and Micromed. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.